HUMAN IMMUNOGLOBULINS
Prolymphocyctic Leukemia
Center for International Blood and Marrow Transplant Researchother_biologicalPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 81/ 100
Competitive context
8 Active assets in the Prolymphocyctic Leukemia cohort.
View all 9 →
Same molecule, other indications
HUMAN IMMUNOGLOBULINS is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →